Why Xinguang Pharma’s Flat Stock Price Signals Deeper Pharma Sector WoesXinguang Pharma’s flat stock day reveals deeper pharma woes—low volume, cautious investors, and a need for clearer growth to beat peers.XINGUANG PHARMAChina Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Vanessa Liu 23/10/2026, 10:27 3 minutes to read
